Telix Pharmaceuticals Ltd Ordinary Shares (ASX:TLX)
APAC company
Share Price Chart
- Chart currently unavailable -
Market Info - TLX
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - TLX
- Market CapAUD0.000m
- SymbolASX:TLX
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINAU000000TLX2
Company Profile
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.Telix Pharmaceuticals Ltd is a biotechnology company. It is engaged in the development and commercialization of molecularly-targeted radiation therapy to address the clinical unmet needs in the management of prostate, renal and glioblastoma cancer.
Latest TLX news
Currently there for this company. Visit our news hub for other news .